MICHAEL ELLIOT KUPFERMAN to Carcinoma, Adenoid Cystic
This is a "connection" page, showing publications MICHAEL ELLIOT KUPFERMAN has written about Carcinoma, Adenoid Cystic.
Connection Strength
1.332
-
Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands. Cancer. 2012 Jun 01; 118(11):2872-8.
Score: 0.283
-
Outcomes of pediatric patients with malignancies of the major salivary glands. Ann Surg Oncol. 2010 Dec; 17(12):3301-7.
Score: 0.259
-
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma. J Clin Oncol. 2023 05 20; 41(15):2843-2851.
Score: 0.156
-
Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets. Clin Cancer Res. 2021 02 01; 27(3):852-864.
Score: 0.133
-
Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605.
Score: 0.116
-
Adenoid cystic carcinoma of the skull base: results with an aggressive multidisciplinary approach. J Neurosurg. 2016 Jan; 124(1):115-21.
Score: 0.092
-
Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head Neck. 2016 04; 38 Suppl 1:E580-7.
Score: 0.092
-
Phase II study of gefitinib in patients with advanced salivary gland cancers. Head Neck. 2015 May; 37(5):644-9.
Score: 0.090
-
An orthotopic murine model of sinonasal malignancy. Clin Cancer Res. 2008 Nov 15; 14(22):7348-57.
Score: 0.058
-
Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer. 2007 Dec 15; 110(12):2726-31.
Score: 0.054